Quick Answer
Tesamorelin tablets, capsules, and oral peptide pills are not the evidence-backed standard. The EGRIFTA SV label describes tesamorelin as a lyophilized powder for injection, reconstituted and injected subcutaneously once daily.
That is the key point: injectable tesamorelin owns the evidence. Future oral peptide technology is not impossible, but an oral tesamorelin product has to prove itself on its own terms. A tablet or capsule should not borrow the clinical credibility of EGRIFTA SV unless it can show credible formulation-specific absorption and outcome data.
Explore the AminoRank tesamorelin profileReview linked studies, category details, and vendor availability for tesamorelin.View tesamorelin profileThe Evidence-Backed Format Is Injectable
The clinical tesamorelin story is built around injection. EGRIFTA SV is supplied as tesamorelin for injection. The label describes reconstitution, subcutaneous abdominal injection, and once-daily dosing.
The major visceral-fat trials also used subcutaneous tesamorelin. That matters because the impressive results people care about, including visceral-fat and waist-profile changes, are attached to injectable clinical use, not tablet claims. When someone says tesamorelin has strong evidence, they are talking about the injectable research and prescription context.
| Format | Evidence status |
|---|---|
| EGRIFTA SV injection | Labeled prescription format with clinical-study support. |
| Research lyophilized vial | Research-product format that requires vendor-quality review. |
| Tablets or capsules | Not the standard evidence-backed tesamorelin format. |
| Oral peptide pills | Should be judged by formulation-specific evidence, not the tesamorelin name alone. |
Why Oral Peptide Claims Need Scrutiny
Peptides are not automatically useful by mouth. Many peptide drugs are degraded in the digestive tract or have poor absorption without specialized formulation technology. That is why injectable formats are common in peptide medicine, especially for larger peptide chains.
Tesamorelin is a 44-amino-acid peptide analog of GHRH. The product that carries the strongest evidence is designed for injection, not for swallowing. An oral product would need to show that enough intact active peptide reaches circulation to create the expected GH/IGF-1 response and body-composition effect.
Tablets Are Not The Same As Convenience
It is easy to understand why people want tesamorelin tablets. A pill sounds easier than reconstitution and injection. But convenience is not the same as absorption, and absorption is the whole issue with an oral peptide claim.
If an oral product cannot show credible absorption, dosing, and outcome data, it should not borrow the clinical credibility of EGRIFTA SV. The ingredient name alone is not enough. For now, the strongest pro-tesamorelin position is also the clearest one: the injectable form is the format with the real evidence behind it.
Oral Dosage Claims
The EGRIFTA SV label gives an injectable dose: 1.4 mg once daily, 0.35 mL after reconstitution. It does not provide oral dosage instructions.
That is the clean answer to tesamorelin oral dosage questions. If a product claims an oral dose, that claim belongs to that specific product and formulation, not to the established EGRIFTA SV evidence base.
What To Look For Before Buying
For injectable research tesamorelin, the product should be clear about vial amount, compound name, and documentation. For oral tesamorelin claims, the bar should be even higher: credible formulation evidence, transparent labeling, and a clear explanation of how the peptide survives digestion and is absorbed.
If that explanation is missing, the more evidence-aligned choice is to compare injectable research listings instead of treating an oral product as equivalent.
Tesamorelin Vendors With Documentation Signals
View all Tesamorelin vendors| Vendor | Country | COAs | Rating | Reviews | Notes | Website |
|---|---|---|---|---|---|---|
| LA Peptides | USA | Yes | 5.0 | 1 | Verified listing | Buy |
| NextGenPeps | USA | Yes | 5.0 | 1 | Verified listing | Buy |
| Alpha Peptides | USA | Yes | 0.0 | 0 | Verified listing | Buy |
| Ascension Peptides | USA | Yes | 0.0 | 0 | Verified listing | Buy |
| BioCollex | USA | Yes | 0.0 | 0 | Verified listing | Buy |
| Coastal Peptides | USA | Yes | 0.0 | 0 | Verified listing | Buy |
When The Calculator Fits
The peptide calculator is relevant to research-vial concentration and syringe-unit math, not oral tablets. If no liquid is being added to a vial, calculator math is not the issue. The issue is whether the oral product has credible evidence.
Use the peptide calculatorCalculate concentration and syringe-unit math for research planning.Open calculatorFAQ
Does tesamorelin come in pill form?
The evidence-backed EGRIFTA SV product is injectable. Pill and capsule claims should be evaluated separately.
Are tesamorelin capsules the same as EGRIFTA SV?
No. EGRIFTA SV is a prescription injectable product.
Why is tesamorelin injected?
Tesamorelin is a peptide, and the established product context uses subcutaneous injection to deliver it.
Should I buy oral tesamorelin?
Do not treat oral tesamorelin claims as equivalent to injectable tesamorelin unless the product has strong formulation-specific evidence.